Nothing Special   »   [go: up one dir, main page]

AU4953693A - Antibody/radioisotope conjugate for tumor diagnosis and/or therapy - Google Patents

Antibody/radioisotope conjugate for tumor diagnosis and/or therapy

Info

Publication number
AU4953693A
AU4953693A AU49536/93A AU4953693A AU4953693A AU 4953693 A AU4953693 A AU 4953693A AU 49536/93 A AU49536/93 A AU 49536/93A AU 4953693 A AU4953693 A AU 4953693A AU 4953693 A AU4953693 A AU 4953693A
Authority
AU
Australia
Prior art keywords
antibody
therapy
tumor diagnosis
radioisotope conjugate
radioisotope
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU49536/93A
Inventor
Brunangelo Falini
Harald Stein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medac Gesellschaft fuer Klinische Spezialpraeparate mbH
Original Assignee
Medac Gesellschaft fuer Klinische Spezialpraeparate mbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medac Gesellschaft fuer Klinische Spezialpraeparate mbH filed Critical Medac Gesellschaft fuer Klinische Spezialpraeparate mbH
Publication of AU4953693A publication Critical patent/AU4953693A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1093—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody conjugates with carriers being antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU49536/93A 1992-08-25 1993-08-25 Antibody/radioisotope conjugate for tumor diagnosis and/or therapy Abandoned AU4953693A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP92250225 1992-08-25
EP92250225 1992-08-25
PCT/EP1993/002293 WO1994004189A1 (en) 1992-08-25 1993-08-25 Antibody/radioisotope conjugate for tumor diagnosis and/or therapy

Publications (1)

Publication Number Publication Date
AU4953693A true AU4953693A (en) 1994-03-15

Family

ID=8211202

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49536/93A Abandoned AU4953693A (en) 1992-08-25 1993-08-25 Antibody/radioisotope conjugate for tumor diagnosis and/or therapy

Country Status (2)

Country Link
AU (1) AU4953693A (en)
WO (1) WO1994004189A1 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2053776C1 (en) * 1994-09-21 1996-02-10 Виктор Владимирович Кешелава Method of oncological disease treatment
DE19543039C1 (en) * 1995-11-08 1996-11-21 Medac Klinische Spezialpraep DNA mols. encoding CD30-specific immunoglobulin variable regions
AU2001286663A1 (en) * 2000-08-28 2002-03-13 Ludwig Institute For Cancer Research Metal radionuclide labelled cd-30 antibodies and uses thereof
EP1471938A4 (en) 2002-01-09 2008-03-05 Medarex Inc Human monoclonal antibodies against cd30
EP1378523A1 (en) * 2002-07-01 2004-01-07 STEIN, Harald, Prof. Dr. Anti-cd30 antibodies and uses thereof
AU2005292227A1 (en) 2004-10-01 2006-04-13 Medarex, Inc. Methods of treating CD30 positive lymphomas
KR101323455B1 (en) 2005-02-18 2013-10-29 메다렉스, 엘.엘.시. Monoclonal antibodies against cd30 lacking fucosyl residues
CZ300074B6 (en) * 2006-12-20 2009-01-21 Azacycles S. R. O. Smart tree-functional macro-conjugates and pharmaceutical composition in which the conjugates are comprised
US8138313B2 (en) 2007-06-15 2012-03-20 Deutsches Krebsforschungszentrum Stiftung Des Offentlichen Rechts Treatment of tumors using specific anti-L1 antibody
PL3200822T3 (en) 2014-09-30 2021-11-08 Deutsches Krebsforschungszentrum, Stiftung Des Öffentlichen Rechts Binding molecules, especially antibodies, binding to l1cam (cd171)
CA3045857A1 (en) 2016-12-22 2018-06-28 Universita Degli Studi Magna Graecia Catanzaro A monoclonal antibody targeting a unique sialoglycosilated cancer-associated epitope of cd43

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991007437A2 (en) * 1989-11-20 1991-05-30 Parker, David, L. Improved cd-30 antibodies and fragments thereof
DK0627940T3 (en) * 1992-03-05 2003-09-01 Univ Texas Use of immunoconjugates for diagnosis and / or therapy of vascularized tumors

Also Published As

Publication number Publication date
WO1994004189A1 (en) 1994-03-03

Similar Documents

Publication Publication Date Title
EP0350230A3 (en) Immunoconjugates for cancer diagnosis and therapy
AU637202B2 (en) Trifunctional antibody-like compounds as a combined diagnostic and therapeutic agent
AU4807185A (en) Antibody therapeutic agent conjugates
AU6785987A (en) Selecting and testing antibodies for cancer therapy
AU5355094A (en) Therapeutic and diagnostic imaging compositions and methods
AU4473596A (en) Methods of human prostate cancer diagnosis
AU2990695A (en) Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
IL101409A0 (en) Method for the early diagnosis of cancer
AU4953693A (en) Antibody/radioisotope conjugate for tumor diagnosis and/or therapy
AU5543494A (en) Method and kit for cancer diagnosis
IL106037A0 (en) Therapeutic and diagnostic methods based on neurotrophin-4-expression
GB9509572D0 (en) Cancer therapy
EP0650372A4 (en) Compounds for cancer imaging and therapy.
EP0370115A4 (en) Catheter for diagnosis and therapy
GB9308166D0 (en) Cancer therapy
AU1809695A (en) Tumor associated monoclonal antibody 123av16
AU1464399A (en) Reagent for tumor therapy and/or imaging
AU3548895A (en) Phosphorus-32 labeling of antibodies for cancer therapy
AU4499196A (en) Antibodies for use in cancer therapy and diagnosis
AU5279996A (en) Antibodies and their use in cancer therapy and diagnosis
AU7231191A (en) Compounds and methods for the treatment and diagnosis of cancer
AU5340394A (en) Anti-metallothionein monoclonal antibody and its diagnostic use
ZA959206B (en) Tumor affinity peptide and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide
AU3430189A (en) Compounds for diagnosis and/or therapy of tumours
AU5135498A (en) Immunoconjugates comprising human monoclonal antibodies or fragments thereof for diagnostic and therapy